No Data
No Data
TD Cowen Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $61
TD Cowen analyst Yaron Werber maintains $Ultragenyx Pharmaceutical(RARE.US)$ with a buy rating, and maintains the target price at $61.According to TipRanks data, the analyst has a success rate of 0.0%
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of AMMO, Inc. (NASDAQ:POWW) fell sharply during Friday's session following fourth-quarter results.AMMO reported a fourth-quarter profit of 1 cent per share, compared to market expectations for
Wedbush Adjusts Ultragenyx Pharmaceutical's Price Target to $45 From $48, Keeps Neutral Rating
Ultragenyx Pharmaceutical (RARE) has an average rating of buy and price targets ranging from $45 to $140, according to analysts polled by Capital IQ. Price: 39.15, Change: -3.97, Percent Change: -9.22
Express News | Ultragenyx Pharmaceutical Shares Are Trading Lower After the Company Priced a $350 Million Public Offering of 7,435,898 Shares at $39 per Share and Prefunded Warrants
Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday
Health care stocks were leaning lower pre-bell Friday with the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) recently declining by 0.3% Cabaletta Bio (CABA) was over 4%
CCORF Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $111
CCORF analyst Whitney Ijem maintains $Ultragenyx Pharmaceutical(RARE.US)$ with a buy rating, and maintains the target price at $111.According to TipRanks data, the analyst has a success rate of 50.0%